ArticleFrontiers in oncology2022

Editorial: Challenges and opportunities of TKIs in the treatment of NSCLC patients with uncommon mutations.

Chunxia Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.